The prostate gland is not the exclusive property of men, women also have it, and it also plays the role of assisting in “ejaculation”, but also get “prostate disease”, what is this all about? The origin and physiological function of the female prostate gland The prostate gland is an accessory gland of the male reproductive system. Although women do not have a “specific” prostate gland, there are also tissues similar to the prostate gland. Around the outlet of the female bladder, there are some glandular tissues whose structure is similar to that of the male prostate. These glandular tissues originate from the same embryonic tissues as the male prostate during the embryonic period, and their secretions have the same composition as that of the male prostate fluid. The female prostate-like tissue is associated with the female erogenous zone (G-zone), which was discovered in 1944 by the German physician Grafeaburg, and thus named for him; the G-zone is located in the middle of the anterior wall of the vagina, and consists of the ducts of the female prostate and their surrounding tissues; in 1950, he again suggested that there is an erectile tissue similar to the corpus cavernosum of the penis, which swells when sexually stimulated and apparently expands toward the vagina, reaching the vagina. Obviously to the vagina, to reach orgasm can appear urethral ejaculation, similar to male ejaculation, later confirmed that the ejaculation of liquid from the female prostate, which contains fructose and PSA, different from urine, also known as vaginal ejaculation, folk also known as “tide blowing”. (Anatomical location of the G-spot) Female prostate vs. male prostate 1, the female prostate and male prostate is originally homologous, due to the different levels of hormones in the body of men and women and developed into different forms, the female prostate due to insufficient stimulation of androgens and failed to fully develop, so the female prostate is much smaller than the male prostate, much thinner. 2, the male reproductive tract and the urethra is the same channel, the male prostate fluid becomes part of the semen, which has an impact on fertility; while the female prostate has no significant impact on fertility. 3, the female prostate is generally not affected by endocrine disorders like the male prostate. Men may cause prostate hyperplasia after middle-age and old age, but women generally do not, but individual cases may also occur in female prostate hyperplasia, which occurs in urination difficulties. The most common female prostate diseases are female prostatitis and female prostatic hyperplasia, so let’s learn more about them. Female prostatitis The symptoms of female prostatitis are varied, manifesting as frequent urination, difficulty urinating, post-pubic pressure, difficulty in sexual intercourse or pain during sexual intercourse, and also hematuria, as well as pain in the lower back, lower abdomen, groin, and thighs; the symptoms are similar to those of lower urinary tract infections, but the mid-urine analysis is not abnormal, and the bacterial cultures are often negative. (I) Diagnosis If a female patient presents with lower urinary tract symptoms such as frequent urination, urinary urgency, painful urination, distension of the perineum, suprapubic region or lower back with painful sexual intercourse, the receiving physician should consider the diagnosis of female prostatitis, and pay special attention to checking the parapubic glands during vaginal palpation, use the fingertips toward the anterior vaginal wall, and press 2/3 of the distal urethra into the flat pubic symphysis, and if the patient complains of obvious pain and yells and twists the If the patient complains of obvious pain and screams, and twists her buttocks to avoid it, and there is no such reaction when pressing the side wall, back wall or other parts of the vagina, normal women press the anterior wall of the vagina somewhat like the male prostate massage, only the sensation of having to urinate, and there is no pain. (b) Treatment of bacterial female prostatitis, regardless of the acute and chronic treatment of antibiotics are the first choice, due to the barrier effect of the epithelial lipid membrane of the prostate follicles, so that a variety of antibiotics can not penetrate into the prostate tissue. The ideal drug for treating prostatitis should have a small molecular weight, be fat-soluble, and have a low binding affinity to proteins so that it is easy to penetrate into the prostate gland. Fluoroquinolones meet these conditions and are composed of the basic structure of 4-pyridinecarboxylic acid, which is acidic, and thus can carry out “ion trapping” in the alkaline secretions of chronic prostatitis in order to Kill microorganisms, antibacterial spectrum, including chlamydia and mycoplasma, of which of the ofloxacin has been approved by the U.S. Food and Drug Administration (FDA) for bacterial prostatitis, their role is to inhibit bacterial DNA replication, transcription and repair of the necessary helicase, resistance is rare, but should not be used in children, so as not to cause chondrogenic disorders, the drug can be passed through the placenta and into the breast milk, therefore, pregnant women and lactating women are prohibited. The drug can pass through the placenta and enter breast milk, so pregnant women and lactating women are prohibited. Prostatic hyperplasia in women Clinically, the tissue around the female bladder that resembles the male prostate is called prostate-like tissue, and because it is similar to male prostatic hyperplasia in terms of symptoms, it is also known as “prostatic hyperplasia” in women. Its symptoms and causes are similar to those of male prostatic hyperplasia. Clinically, it is most common in middle-aged and old-aged people, especially in elderly women, and its incidence tends to increase with the age of the population. (A) etiology (1) long-term chronic inflammatory stimulation of the urethra, so that the mucosa and submucosa of the bladder neck edema, fibrous tissue proliferation, smooth muscle hyperplasia and hypertrophy of the bladder neck. With age, the estrogen level in women’s bodies decreases, and the imbalance of sex hormone levels can lead to periurethral glandular hyperplasia. (B) Diagnosis As female prostatic hyperplasia is not common in the clinic, it is very easy to misdiagnose it only based on the patient’s complaints, clinical manifestations, physical examination and urine examination, and it needs to be combined with ultrasonography, cystourethroscopy, urodynamics and other tests for comprehensive analysis to make a correct diagnosis. Ultrasound diagnostic criteria: the bladder neck hypoechoic mass is enlarged, longitudinal section shows that the tip of the bladder neck downward triangular hypoechoic mass thickened lip-like to the bladder, transverse section shows that the bladder neck hypoechoic mass is full shaped like a male prostate gland, the transverse diameter ≥ 1.5 cm, anterior and posterior diameters ≥ 1.0 cm, the circumference ≥ 3.5 cm. cystourethroscopy shows that there are varying degrees of trabecular hyperplasia in the bladder wall, and the posterior lip of the bladder neck bulging in the form of a dyke, and there is chronic inflammation in the proximal urethra, and there is chronic inflammation in the proximal urethra. and chronic inflammatory changes in the proximal part of the urethra, which can help in the diagnosis of the disease and also exclude lesions of the urethra and bladder. (C) Treatment For early patients with mild symptoms, urethral dilatation is feasible, and at the same time, α1-blockers and estrogen can be taken. α1-blockers can relax the smooth muscle of the bladder neck and reduce the resistance of the bladder and urethra; estrogen improves the nutrition of the epithelium, promotes blood circulation, and enhances urethral tone, so the efficacy of the treatment is remarkable. For those who have obvious difficulty in urination, Qmax<15ml/s, residual urine volume>60ml, and cystourethroscopy confirms that there is bladder neck outlet obstruction, they should be treated with bladder neck electrolysis. For those with urinary tract infection, renal or ureteral fluid, and renal insufficiency, preoperative application of antimicrobial drugs and indwelling catheter for continuous drainage should be performed, and surgical treatment should be carried out after the infection is controlled and renal function is improved. In the future, when someone mentioned to you the prostate or prostate-related diseases, do not think of only men Oh, women also have prostate-like tissue, can also get prostate-related diseases.